1 October 2023 v2025.36.1 limited_company_frs_102_section_1a_v1_1_2 companies_houseSoftwarefalsetruetruetrueNo description of principal activityfalsetruexbrli:purexbrli:sharesiso4217:GBP103746792023-10-012024-09-30103746792024-09-30103746792023-09-3010374679core:WithinOneYear2024-09-3010374679core:WithinOneYear2023-09-3010374679core:AfterOneYear2024-09-3010374679core:AfterOneYear2023-09-3010374679core:ShareCapital2024-09-3010374679core:ShareCapital2023-09-3010374679core:RetainedEarningsAccumulatedLosses2024-09-3010374679core:RetainedEarningsAccumulatedLosses2023-09-3010374679bus:Director12023-10-012024-09-3010374679bus:RegisteredOffice2023-10-012024-09-3010374679core:OfficeEquipment2023-10-012024-09-30103746792022-10-012023-09-3010374679core:PlantMachinery2024-09-3010374679core:PlantMachinery2023-10-0110374679core:PlantMachinery2023-10-012024-09-3010374679core:PlantMachinery2023-09-301037467912023-10-012024-09-3010374679countries:EnglandWales2023-10-012024-09-3010374679bus:AuditExempt-NoAccountantsReport2023-10-012024-09-3010374679bus:PrivateLimitedCompanyLtd2023-10-012024-09-3010374679bus:SmallEntities2023-10-012024-09-3010374679bus:FullAccounts2023-10-012024-09-30
Company registration number:
10374679
KMX Healthcare Ltd
Unaudited Filleted Financial Statements for the year ended
30 September 2024
KMX Healthcare Ltd
Statement of Financial Position
30 September 2024
20242023
Note££
Fixed assets    
Tangible assets 5
958
 
1,127
 
Current assets    
Stocks
58,946
 
116,059
 
Debtors 6
155,526
 
57,804
 
Cash at bank and in hand
25,054
 
31,142
 
239,526
 
205,005
 
Creditors: amounts falling due within one year 7
(123,479
)
(190,143
)
Net current assets
116,047
 
14,862
 
Total assets less current liabilities 117,005   15,989  
Creditors: amounts falling due after more than one year 8
(147,406
)
(16,667
)
Net liabilities
(30,401
)
(678
)
Capital and reserves    
Called up share capital
1
 
1
 
Profit and loss account
(30,402
)
(679
)
Shareholders deficit
(30,401
)
(678
)
For the year ending
30 September 2024
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
13 June 2025
, and are signed on behalf of the board by:
Mr. M Williamson
Director
Company registration number:
10374679
KMX Healthcare Ltd
Notes to the Financial Statements
Year ended
30 September 2024

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
20-22 Wenlock Road
,
London
,
N1 7GU
, England.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.
Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Office equipment
15% reducing balance

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

4 Average number of employees

The average number of persons employed by the company during the year was
1
(2023:
1
).

5 Tangible assets

Plant and machinery etc.
£
Cost  
At
1 October 2023
and
30 September 2024
2,540
 
Depreciation  
At
1 October 2023
1,413
 
Charge
169
 
At
30 September 2024
1,582
 
Carrying amount  
At
30 September 2024
958
 
At 30 September 2023
1,127
 

6 Debtors

20242023
££
Trade debtors
16,345
 
18,203
 
Amounts owed by group undertakings and undertakings in which the company has a participating interest
3,942
 
2,908
 
Other debtors
135,239
 
36,693
 
155,526
 
57,804
 

7 Creditors: amounts falling due within one year

20242023
££
Bank loans and overdrafts
45,315
 
95,500
 
Trade creditors
18,148
 
25,414
 
Taxation and social security
41,032
 
39,022
 
Other creditors
18,984
 
30,207
 
123,479
 
190,143
 

8 Creditors: amounts falling due after more than one year

20242023
££
Bank loans and overdrafts
147,406
 
16,667
 

9 Directors' advances, credit and guarantees

During the year, KMX Healthcare Ltd granted an unsecured, interest-free loan to Mr. M Williamson to the value of £87,584. The loan is repayable on demand and in full. The loans have been repaid as at the reporting date.